News Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD Continue Reading Previous Letter to Shareholders and Corporate UpdateNext Oxurion Announces Key Amendments to Atlas and Kreos/Pontifax Agreements Enabling KALAHARI Trial to Progress to Topline Results in 2023 Related Stories News Senteon Expands Automated Endpoint Hardening to Microsoft Office News Ninety Launches Ask Maz, Turning Business Data Into Answers for EOS Leadership Teams News OnStation Makes Every Road Project Digital with New Self-Serve Project Creation Tool News Middle East Tensions Rise, CAC 40 Falls, Gold and Oil Swing, MoneySimpler Launches AI Passive Income Bot News The Benevity State of Corporate Purpose 2026 Report Finds Corporate Giving Is Up Eight Points As Companies Face Socio-Political Pressure News ATHA Energy Reports Widest Intersection to Date at Rib North Discovery with 37 m of Composite Uranium Mineralization in Ribn-DD-003 – Multiple Drillholes Demonstrating Continuity of Uranium Mineralization
